tradingkey.logo

Haemonetics Corp

HAE
View Detailed Chart

50.600USD

-0.550-1.08%
Close 09/19, 16:00ETQuotes delayed by 15 min
2.44BMarket Cap
14.92P/E TTM

Haemonetics Corp

50.600

-0.550-1.08%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.08%

5 Days

-3.07%

1 Month

-6.81%

6 Months

-22.43%

Year to Date

-35.19%

1 Year

-32.61%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
60 / 207
Overall Ranking
140 / 4720
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 11 analysts
Buy
Current Rating
80.300
Target Price
+56.99%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 16.44% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 45.30.
Undervalued
The company’s latest PE is 15.40, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 57.31M shares, decreasing 6.82% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 4.94M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.27.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Ticker SymbolHAE
CompanyHaemonetics Corp
CEOMr. Christopher A. Simon
Websitehttps://www.haemonetics.com
KeyAI